Evidence map›Paper›PMID 15731339›Full record

ArticleNucleic acids research2005

Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant.

Melissa A Calmann, Anetta Nowosielska, M G Marinus

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Mechanisms That Govern Recombinase Fidelity Control During Eukaryotic Homologous Recombination.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. The Role of theGenes · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DNA Mismatch Repair.EcoSal Plus · 2012
    Article
  13. Article
  14. DNA mismatch repair in eukaryotes and bacteria.Journal of nucleic acids · 2010
    Article
  15. Article
  16. Article
  17. The frequency and structure of recombinant products is determined by the cellular level of MutL.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melissa A CalmannDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School 364 Plantation Street, Worcester, MA 01605, USA.
Anetta Nowosielska
M G Marinus
University of Massachusetts Chan Medical School · US

Funding

DNA Mismatch and Double-Strand Break RepairR01GM063790 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MARINUS, MARTIN G. · 2002 to 2010
$2.6M
NIGMS NIH HHS GM63790NIGMS NIH HHS R01 GM063790
6 · The paper itself

Abstract

DNA mismatch repair in Escherichia coli has been shown to be involved in two distinct processes: mutation avoidance, which removes potential mutations arising as replication errors, and antirecombination which prevents recombination between related, but not identical (homeologous), DNA sequences. We show that cells with the mutSDelta800 mutation (which removes the C-terminal 53 amino acids of MutS) on a multicopy plasmid are proficient for mutation avoidance. In interspecies genetic crosses, however, recipients with the mutSDelta800 mutation show increased recombination by up to 280-fold relative to mutS+. The MutSDelta800 protein binds to O6-methylguanine mismatches but not to intrastrand platinated GG cross-links, explaining why dam bacteria with the mutSDelta800 mutation are resistant to cisplatin, but not MNNG, toxicity. The results indicate that the C-terminal end of MutS is necessary for antirecombination and cisplatin sensitization, but less significant for mutation avoidance. The inability of MutSDelta800 to form tetramers may indicate that these are the active form of MutS.

Indexed as

DNA RepairMutationRecombination, GeneticAdenosine TriphosphatasesBacterial ProteinsBase Pair MismatchCisplatinConjugation, GeneticCrosses, GeneticDNA-Binding ProteinsDNA HelicasesEscherichia coliEscherichia coli ProteinsMutS DNA Mismatch-Binding ProteinOligonucleotidesAdenosine TriphosphatasesBacterial ProteinsCisplatinDNA-Binding ProteinsDNA HelicasesEscherichia coli ProteinsMutS DNA Mismatch-Binding ProteinMutS protein, E coliOligonucleotides

Identifiers

PMID15731339
PMCPMC549567
OpenAlexW2158925696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.